Molecular cloning and expression of a rat Via arginine vasopressin receptor
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The neurohypophyseal hormone arginine vasopressin has diverse actions, including the inhibition of diuresis, contraction of smooth muscle, stimulation of liver glycogenolysis and modulation of adrenocorticotropic hormone release from the pituitary. Arginine vasopressin receptors are G protein-coupled and have been divided into at least three types; the V1a (vascular/hepatic) and V1b (anterior pituitary) receptors which act through phosphatidylinositol hydrolysis to mobilize intracellular Ca2+, and the V2 (kidney) receptor which is coupled to adenylate cyclase. We report here the cloning of a complementary DNA encoding the hepatic V1a arginine vasopressin receptor. The liver cDNA encodes a protein with seven putative transmembrane domains, which binds arginine vasopressin and related compounds with affinities similar to the native rat V1a receptor. The messenger RNA corresponding to the cDNA is distributed in rat tissues known to contain V1a receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One is impaired intracellular glucose metabolism due to increased gluconeogenesis and/or increased glycogenolysis as suggested by acute experiments [31,32], an effect probably related to V1aR activation [29].”
From Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats (2015) · cites this paper as [29]
Citations
Cites
High-efficiency transformation of mammalian cells by plasmid DNA.
Chen, C., & Okayama, H. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2745 · Cited by 5,373
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Self-citationCompilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs
Kozak, M. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.2.857 · Cited by 3,293
Cloning and expression of a cDNA encoding an endothelin receptor
Arai, H., Hori, S., Aramori, I., Ohkubo, H., & Nakanishi, S. (1990) · Nature · doi:10.1038/348730a0 · Cited by 2,578
Cloning and expression of a rat D2 dopamine receptor cDNA
Bunzow, J. R., Tol, H. H. M. V., Grandy, D. K., Albert, P., Salon, J., Christie, M., Machida, C. A., Neve, K. A., & Civelli, O. (1988) · Nature · doi:10.1038/336783a0 · Cited by 1,117
Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin
Gillies, G. E., Linton, E. A., & Lowry, P. J. (1982) · Nature · doi:10.1038/299355a0 · Cited by 965
Repetitive transient rises in cytoplasmic free calcium in hormone-stimulated hepatocytes
Woods, N. M., Cuthbertson, K. S. R., & Cobbold, P. H. (1986) · Nature · doi:10.1038/319600a0 · Cited by 793
Cloning and expression of cDNA for a human thromboxane A2 receptor
Hirata, M., Hayashi, Y., Ushikubi, F., Yokota, Y., Kageyama, R., Nakanishi, S., & Narumiya, S. (1991) · Nature · doi:10.1038/349617a0 · Cited by 684
Structure and expression of a human oxytocin receptor
Kimura, T., Tanizawa, O., Mori, K., Brownstein, M. J., & Okayama, H. (1992) · Nature · doi:10.1038/356526a0 · Cited by 632
Self-citationKobilka, B. K., Frielle, T., Collins, S., Yang-Feng, T., Kobilka, T. S., Francke, U., Lefkowitz, R. J., & Caron, M. G. (1987) · Nature · doi:10.1038/329075a0 · Cited by 515
Research works printed but not linked: 5
- Matsuguchi, H., Schmid, P. G., Gorden, F. J. & Johnson, A. K. Physiologist 23, 29–33 (1980).
- Clements, J. A. & Funder, J. W. Endocr. Rev. 116, 416–423 (1986).
- Butlen, D. et al. Molec. Pharmac. 14, 1006–1017 (1978).
- Kozak, M. Nucleic Acids Res. 12, 857–872 (1984). · DOI · Paper page
- Bunzow, J. R. et al. Nature 336, 783–787 (1988). · DOI · Paper page
Cited by
O'Dowd, B. F., Heiber, M., Chan, A., Heng, H. H. Q., Tsui, L.-C., Kennedy, J. L., Shi, X., Petronis, A., George, S. R., & Nguyen, T. (1993) · Gene · doi:10.1016/0378-1119(93)90495-o · Cited by 851
Simonneaux, V., & Ribelayga, C. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.2.2 · Cited by 740
Goodson, J. L., & Bass, A. H. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00043-1 · Cited by 636
Lolait, S. J., O'Carroll, A.-M., McBride, O. W., Konig, M., Morel, A., & Brownstein, M. J. (1992) · Nature · doi:10.1038/357336a0 · Cited by 524
Self-citationGα15 and Gα16 Couple a Wide Variety of Receptors to Phospholipase C
Offermanns, S., & Simon, M. I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.25.15175 · Cited by 498
Sodium-Potassium-Adenosinetriphosphatase-Dependent Sodium Transport in the Kidney: Hormonal Control
Féraille, E., & Doucet, A. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.1.345 · Cited by 500
Griebel, G., Simiand, J., Serradeil-Le Gal, C., Wagnon, J., Pascal, M., Scatton, B., Maffrand, J.-P., & Soubrié, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092012099 · Cited by 471
Neuroendocrine Control of Body Fluid Metabolism
ANTUNES-RODRIGUES, J., DE CASTRO, M., ELIAS, L. L. K., VALENÇA, M. M., & McCANN, S. M. (2004) · Physiological Reviews · doi:10.1152/physrev.00017.2003 · Cited by 468
Physiological Regulation of G Protein-Linked Signaling
Morris, A. J., & Malbon, C. C. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1373 · Cited by 449
Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics
Manning, M., Misicka, A., Olma, A., Bankowski, K., Stoev, S., Chini, B., Durroux, T., Mouillac, B., Corbani, M., & Guillon, G. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2012.02303.x · Cited by 423
Vasopressin V1a and V1b Receptors: From Molecules to Physiological Systems
Koshimizu, T.-A., Nakamura, K., Egashira, N., Hiroyama, M., Nonoguchi, H., & Tanoue, A. (2012) · Physiological Reviews · doi:10.1152/physrev.00035.2011 · Cited by 407
Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor.
Sugimoto, T., Saito, M., Mochizuki, S., Watanabe, Y., Hashimoto, S., & Kawashima, H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47129-3 · Cited by 378
Aguilera, G., & Rabadan-Diehl, C. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00196-8 · Cited by 375
Do Rego, J. L., Seong, J. Y., Burel, D., Leprince, J., Luu-The, V., Tsutsui, K., Tonon, M.-C., Pelletier, G., & Vaudry, H. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.05.006 · Cited by 357
Ectopic and Abnormal Hormone Receptors in Adrenal Cushing’s Syndrome*
Lacroix, A., N′Diaye, N., Tremblay, J., & Hamet, P. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.1.0420 · Cited by 350
Birnbaumer, M. (2000) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00304-0 · Cited by 342
Landgraf, R., Gerstberger, R., Montkowski, A., Probst, J., Wotjak, C., Holsboer, F., & Engelmann, M. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-06-04250.1995 · Cited by 341
Yamamura, Y., Nakamura, S., Itoh, S., Hirano, T., Onogawa, T., Yamashita, T., Yamada, Y., Tsujimae, K., Aoyama, M., Kotosai, K., et al. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37873-5 · Cited by 337
Extrapituitary expression of the rat V1b vasopressin receptor gene.
Lolait, S. J., O'Carroll, A. M., Mahan, L. C., Felder, C. C., Button, D. C., Young, W. S., Mezey, E., & Brownstein, M. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.6783 · Cited by 337
Self-citationVaccari, C., Lolait, S. J., & Ostrowski, N. L. (1998) · Endocrinology · doi:10.1210/endo.139.12.6382 · Cited by 308
AKI Associated with Cardiac Surgery
Thiele, R. H., Isbell, J. M., & Rosner, M. H. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07830814 · Cited by 308
Plasma Copeptin and the Risk of Diabetes Mellitus
Enhörning, S., Wang, T. J., Nilsson, P. M., Almgren, P., Hedblad, B., Berglund, G., Struck, J., Morgenthaler, N. G., Bergmann, A., Lindholm, E., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.909663 · Cited by 299
Hyponatremia in cirrhosis: From pathogenesis to treatment†
Ginés, P., Berl, T., Bernardi, M., Bichet, D. G., Hamon, G., Jiménez, W., Liard, J.-F., Martin, P.-Y., & Schrier, R. W. (1998) · Hepatology · doi:10.1002/hep.510280337 · Cited by 299
MANNING, M., STOEV, S., CHINI, B., DURROUX, T., MOUILLAC, B., & GUILLON, G. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00437-8 · Cited by 296
Thibonnier, M., Auzan, C., Madhun, Z., Wilkins, P., Berti-Mattera, L., & Clauser, E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41863-1 · Cited by 283
Serradeil-Le Gal, C., Wagnon, J., Garcia, C., Lacour, C., Guiraudou, P., Christophe, B., Villanova, G., Nisato, D., Maffrand, J. P., & Le Fur, G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116554 · Cited by 270
The aquaporin family of water channels in kidney
Nielsen, S., & Agre, P. (1995) · Kidney International · doi:10.1038/ki.1995.389 · Cited by 265
The Binding Site of Neuropeptide Vasopressin V1a Receptor
Mouillac, B., Chini, B., Balestre, M.-N., Elands, J., Trumpp-Kallmeyer, S., Hoflack, J., Hibert, M., Jard, S., & Barberis, C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25771 · Cited by 262
Tanoue, A., Ito, S., Honda, K., Oshikawa, S., Kitagawa, Y., Koshimizu, T., Mori, T., & Tsujimoto, G. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19656 · Cited by 258
Serradeil-Le Gal, C., Lacour, C., Valette, G., Garcia, G., Foulon, L., Galindo, G., Bankir, L., Pouzet, B., Guillon, G., Barberis, C., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119098 · Cited by 250
The Mouse Defense Test Battery: pharmacological and behavioral assays for anxiety and panic
Blanchard, D. C., Griebel, G., & Blanchard, R. J. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01276-7 · Cited by 295
Reinhart, J., Mertz, L. M., & Catt, K. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36602-5 · Cited by 242
Vasopressin: a novel target for the prevention and retardation of kidney disease?
Bankir, L., Bouby, N., & Ritz, E. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.22 · Cited by 214
Young, L. J., Winslow, J. T., Nilsen, R., & Insel, T. R. (1997) · Behavioral Neuroscience · doi:10.1037/0735-7044.111.3.599 · Cited by 196
Cloning and characterization of the human V3 pituitary vasopressin receptor
de Keyzer, Y., Auzan, C., Lenne, F., Beldjord, C., Thibonnier, M., Bertagna, X., & Clauser, E. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)01268-7 · Cited by 209
The Hypothalamus and Hypertension
De Wardener, H. E. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.4.1599 · Cited by 205
Zachary, I., Sinnett-Smith, J., Turner, C. E., & Rozengurt, E. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80648-6 · Cited by 202
Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?
Griebel, G., & Holsboer, F. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3702 · Cited by 194
Structure, characterization, and expression of the rat oxytocin receptor gene.
Rozen, F., Russo, C., Banville, D., & Zingg, H. H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.1.200 · Cited by 191
Plasma Copeptin, A Unifying Factor behind the Metabolic Syndrome
Enhörning, S., Struck, J., Wirfält, E., Hedblad, B., Morgenthaler, N. G., & Melander, O. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2981 · Cited by 177
van den Ouweland, A. M. W., Dreesen, J. C. F. M., Verdijk, M., Knoers, N. V. A. M., Monnens, L. A. H., Rocchi, M., & van Oost, B. A. (1992) · Nature Genetics · doi:10.1038/ng1092-99 · Cited by 183
Cloning and identification of an oxytocin/vasopressin-like receptor and its ligand from insects
Stafflinger, E., Hansen, K. K., Hauser, F., Schneider, M., Cazzamali, G., Williamson, M., & Grimmelikhuijzen, C. J. P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710897105 · Cited by 180
Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor
Chini, B., Mouillac, B., Ala, Y., Balestre, M. N., Trumpp‐Kallmeyer, S., Hoflack, J., Elands, J., Hibert, M., Manning, M., & Jard, S. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07211.x · Cited by 179
Nephrogenic Diabetes Insipidus
Bichet, D. G. (2006) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2006.01.006 · Cited by 174
Localization of oxytocin receptor messenger ribonucleic acid in the rat brain.
Yoshimura, R., Kiyama, H., Kimura, T., Araki, T., Maeno, H., Tanizawa, O., & Tohyama, M. (1993) · Endocrinology · doi:10.1210/endo.133.3.8396014 · Cited by 161
Ostrowski, N. L., Young, W. S., Knepper, M. A., & Lolait, S. J. (1993) · Endocrinology · doi:10.1210/endo.133.4.8404628 · Cited by 154
Structure, function, and phylogeny of [Arg8]vasotocinreceptors from teleost fish and toad.
Mahlmann, S., Meyerhof, W., Hausmann, H., Heierhorst, J., Schönrock, C., Zwiers, H., Lederis, K. P., & Richter, D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.4.1342 · Cited by 153
Vasopressin V2receptor expression along rat, mouse, and human renal epithelia with focus on TAL
Mutig, K., Paliege, A., Kahl, T., Jöns, T., Müller‐Esterl, W., & Bachmann, S. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00196.2007 · Cited by 146
Molecular Pharmacology of Human Vasopressin Receptors
Thibonnier, M., Conarty, D. M., Preston, J. A., Wilkins, P. L., Berti‐Mattera, L. N., & Mattera, R. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4871-3_34 · Cited by 144
The Central Vasopressinergic System: Examining the Opportunities for Psychiatric Drug Development
Ring, R. H. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053382241 · Cited by 145
Expression and Signal Transduction Pathways of Gonadotropin-Releasing Hormone Receptors
Stojilković, S. S., & Catt, K. J. (1995) · Elsevier eBooks · doi:10.1016/b978-0-12-571150-0.50012-3 · Cited by 141
Vasopressinergic regulation of the hypothalamic pituitary adrenal axis and stress adaptation
Volpi, S., Rabadan-Diehl, C., & Aguilera, G. (2004) · Stress · doi:10.1080/10253890410001733535 · Cited by 136
“…G-protein, Gs, and adenylate cyclase; V1a receptors, present in smooth muscle and liver, coupled to phospholipase C (PLC); and the pituitary V1b receptors (V1bR or V3), also linked to PLC; (Lolait et al., 1992; Morel et al., 1992; Seibold et al., 1992; Sumimoto et al., 1994; Lolait et al., 1995).”
BackgroundVasopressin and oxytocin receptors
Zingg, H. H. (1996) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(96)80314-4 · Cited by 139
The molecular basis of nephrogenic diabetes insipidus
Oksche, A., & Rosenthal, W. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050224 · Cited by 137
Flanagan, C. A., Becker, I. I., Davidson, J. S., WAKEFIELD, I. K., Zhou, W., Sealfon, S. C., & Millar, R. P. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31693-9 · Cited by 136
Li, J., Burton, K. J., Zhang, C., Hu, S.-B., & Zhou, Q. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90463.2008 · Cited by 146
Terada, Y., Tomita, K., Nonoguchi, H., Yang, T., & Marumo, F. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116838 · Cited by 135
Liu, J., & Wess, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.15.8772 · Cited by 135
Nonoguchi, H., Owada, A., Kobayashi, N., Takayama, M., Terada, Y., Koike, J., Ujiie, K., Marumo, F., Sakai, T., & Tomita, K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118222 · Cited by 132
Thibonnier, M., Preston, J. A., Dulin, N. O., Wilkins, P. L., Berti‐Mattera, L. N., & Mattera, R. (1997) · Endocrinology · doi:10.1210/endo.138.10.5432 · Cited by 138
Distribution of messenger RNA for the vasopressin V1a receptor in the CNS of male and female rats
Szot, P., Bale, T. L., & Dorsa, D. M. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90111-2 · Cited by 125
Clark, J., Moore, L. E., Krasinskas, A. M., Way, J., Battey, J. F., Tamkun, J. W., & Kahn, R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.8952 · Cited by 123
Bernard, K. F., Bogliolo, S., & Ehrenfeld, J. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706103 · Cited by 121
Rood, B. D., Stott, R. T., You, S., Smith, C. J. W., Woodbury, M. E., & De Vries, G. J. (2013) · Journal of Comparative Neurology · doi:10.1002/cne.23288 · Cited by 120
Chini, B., Mouillac, B., Balestre, M.-N., Trumpp-Kallmeyer, S., Hoflack, J., Hibert, M., Andriolo, M., Pupier, S., Jard, S., & Barberis, C. (1996) · FEBS Letters · doi:10.1016/s0014-5793(96)01135-0 · Cited by 117
Molecular neurobiology and pharmacology of the Vasopressin/Oxytocin receptor family
Burbach, J. P. H., Burbach, H., Adan, R. A. H., Lolait, S. J., van Leeuwen, F. W., Mezey, É., Palkovits, M., & Barberis, C. (1995) · Cellular and Molecular Neurobiology · doi:10.1007/bf02071318 · Cited by 119
The vasopressin Avpr1b receptor: Molecular and pharmacological studies
Roper, J. A., O'Carroll, A.-M., Young, W. S., & Lolait, S. (2010) · Stress · doi:10.3109/10253890.2010.512376 · Cited by 129
Self-citationCognitive Enhancement Therapy for Alzheimerʼs Disease: The Way Forward
Parnetti, L., Senin, U., & Mecocci, P. (1997) · Drugs · doi:10.2165/00003495-199753050-00003 · Cited by 133
Tolvaptan, an Orally Active Vasopressin V2‐Receptor Antagonist—Pharmacology and Clinical Trials
Miyazaki, T., Fujiki, H., Yamamura, Y., Nakamura, S., & Mori, T. (2007) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2007.00001.x · Cited by 125
Alteration of Glucose Homeostasis in V1a Vasopressin Receptor-Deficient Mice
Aoyagi, T., Birumachi, J.-I., Hiroyama, M., Fujiwara, Y., Sanbe, A., Yamauchi, J., & Tanoue, A. (2007) · Endocrinology · doi:10.1210/en.2006-1315 · Cited by 113
Co-evolution of Ligand-Receptor Pairs in the Vasopressin/Oxytocin Superfamily of Bioactive Peptides
van Kesteren, R. E., Tensen, C. P., Smit, A. B., van Minnen, J., Kolakowski, L. F., Meyerhof, W., Richter, D., van Heerikhuizen, H., Vreugdenhil, E., & Geraerts, W. P. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.7.3619 · Cited by 125
Thibonnier, M., Berti‐Mattera, L. N., Dulin, N. O., Conarty, D. M., & Mattera, R. (1999) · Progress in brain research · doi:10.1016/s0079-6123(08)61568-x · Cited by 112
Protein- and diabetes-induced glomerular hyperfiltration: role of glucagon, vasopressin, and urea
Bankir, L., Roussel, R., & Bouby, N. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00614.2014 · Cited by 118
Vasopressin‐induced intracellular Ca2+ increase in isolated rat supraoptic cells.
Dayanithi, G., Widmer, H., & Richard, P. (1996) · The Journal of Physiology · doi:10.1113/jphysiol.1996.sp021180 · Cited by 113
Ala, Y., Morin, D., Mouillac, B., Sabatier, N., Vargas‐Poussou, R., de la Cotte, N., Déchaux, M., Antignac, C., Arthus, M., Lonergan, M., et al. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v9101861 · Cited by 111
Landgraf, R. (1995) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1995.tb00754.x · Cited by 113
The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome.
de Keyzer, Y., Lenne, F., Auzan, C., Jégou, S., René, P., Vaudry, H., Kuhn, J., LUTON, J. P., Clauser, É., & BERTAGNA, X. Y. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118547 · Cited by 104
Hauser, F., Søndergaard, L., & Grimmelikhuijzen, C. J. P. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9230 · Cited by 108
Offermanns, S., Iida‐Klein, A., Segre, G. V., & Simon, M. I. (1996) · Molecular Endocrinology · doi:10.1210/mend.10.5.8732687 · Cited by 108
Oshikawa, S., Tanoue, A., Koshimizu, T.-A., Kitagawa, Y., & Tsujimoto, G. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.3.623 · Cited by 105
Hormonal regulation of ion and water transport in anuran amphibians
Uchiyama, M., & Konno, N. (2006) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2005.12.018 · Cited by 105
Nephrogenic diabetes insipidus
Bichet, D. G. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00301-5 · Cited by 105
Breton, C., Péchoux, C., Morel, G., & Zingg, H. H. (1995) · Endocrinology · doi:10.1210/endo.136.7.7540544 · Cited by 104
Overview of cellular electrophysiological actions of vasopressin
Raggenbass, M. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.074 · Cited by 117
Hurbin, A., Boissin‐Agasse, L., Orcel, H., Rabié, A., Joux, N., Desarménien, M. G., Richard, P., & Moos, F. (1998) · Endocrinology · doi:10.1210/endo.139.11.6320 · Cited by 103
Gorbulev, V., BÜCHNER, H., Akhundova, A., & Fahrenholz, F. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18000.x · Cited by 100
Marie, J., Maigret, B., Joseph, M.-P., Larguier, R., Nouet, S., Lombard, C., & Bonnafous, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31893-8 · Cited by 99
Calcitonin Receptor-stimulating Peptide, a New Member of the Calcitonin Gene-related Peptide Family
Katafuchi, T., Kikumoto, K., Hamano, K., Kangawa, K., Matsuo, H., & Minamino, N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207970200 · Cited by 95
Wheatley, M. (1999) · Human Reproduction Update · doi:10.1093/humupd/5.4.356 · Cited by 95
Guerra, M. T., Florentino, R. M., França, A., Filho, A. C. L., dos Santos, M. L., Fonseca, R. C., Lemos, F. O., Fonseca, M. D. C., Kruglov, E. A., Mennone, A., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317811 · Cited by 94
Tuftsin: On the 30-year anniversary of Victor Najjar’s discovery
Siemion, I. Z., & Kluczyk, A. (1999) · Peptides · doi:10.1016/s0196-9781(99)00019-4 · Cited by 91
Litvin, Y., Murakami, G., & Pfaff, D. W. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.03.007 · Cited by 104
Vasopressin and Oxytocin in Control of the Cardiovascular System
Japundžić‐Žigon, N. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311020008 · Cited by 98
Cytokine-mediated downregulation of vasopressin V1Areceptors during acute endotoxemia in rats
Bucher, M., Hobbhahn, J., Taeger, K., & Kurtz, A. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00520.2001 · Cited by 90
Regulation of Pituitary Vasopressin V1b Receptor mRNA during Stress in the Rat
Rabadan‐Diehl, C., Lolait, S. J., & Aguilera, G. (1995) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1995.tb00734.x · Cited by 86
Young, L. J., Wang, Z., Cooper, T. T., & Albers, H. E. (2000) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2000.00573.x · Cited by 88
Molecular biology of vasopressin receptors
LOLAIT, S. J., O'CARROLL, A., & BROWNSTEIN, M. J. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44688.x · Cited by 87
Self-citationMolecular and functional characterization of V1b vasopressin receptor in rat adrenal medulla
Grazzini, E., Lodboerer, A. M., Pérez‐Martin, A., BRESSION, D., & Guillon, G. (1996) · Endocrinology · doi:10.1210/endo.137.9.8756565 · Cited by 87
Taveau, C., Chollet, C., Waeckel, L., Desposito, D., Bichet, D. G., Arthus, M.-F., Magnan, C., Philippe, E., Paradis, V., Foufelle, F., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3496-9 · Cited by 86
Granot, Y., ERIKSON, E., Fridman, H., Putten, V. V., Williams, B., Schrier, R. W., & Maller, J. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98388-2 · Cited by 86
Metadata
- Authors
- Morel, A., O'Carroll, A.-M., Brownstein, M. J., & Lolaft, S. J.
- Affiliations
- National Institutes of Health (US)
- ORCID
- Morel, Alain
- Venue
- Nature
- Published
- 1992-04
- Volume
- 356
- Issue
- 6369
- Pages
- 523-526
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2007060613
- Semantic Scholar
- e3358299b468c8f7ee7c12e49293b5113bd0ce45
- Cited by
- 477
- References
- 29
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 1 · 2023: 4 · 2022: 7 · 2021: 7 · 2020: 1 · 2019: 7 · 2018: 4 · 2017: 3 · 2016: 9 · 2015: 4 · 2014: 7 · 2013: 11 · 2012: 9
- FWCI
- 80.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- arginine vasopressin receptor, V1a receptor, G protein-coupled receptors, cDNA cloning, rats, receptor structure, transmembrane domain, ligand binding affinity, mRNA distribution, liver glycogenolysis, diuresis
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Cell Line, Cloning, Molecular, Dose-Response Relationship, Drug, Female, Cricetinae, Kidney, Liver, Molecular Sequence Data, Ovary, Receptors, Angiotensin, Recombinant Proteins, RNA, Messenger, Sequence Homology, Nucleic Acid, Spleen, Xenopus, Blotting, Northern, Gene Library, Receptors, Vasopressin, GTP-Binding Proteins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.